| Primary |
| Eczema Infantile |
15.0% |
| Product Used For Unknown Indication |
8.3% |
| Psoriasis |
8.3% |
| Eczema |
6.7% |
| Osteoarthritis |
6.7% |
| Dermatitis Atopic |
5.0% |
| Fungal Infection |
5.0% |
| Metastases To Liver |
5.0% |
| Premature Rupture Of Membranes |
5.0% |
| Vitamin Supplementation |
5.0% |
| Asthma |
3.3% |
| Drug Use For Unknown Indication |
3.3% |
| Intervertebral Disc Protrusion |
3.3% |
| Lumbar Radiculopathy |
3.3% |
| Premature Delivery |
3.3% |
| Rash |
3.3% |
| Rosacea |
3.3% |
| Skin Irritation |
3.3% |
| Acne |
1.7% |
| Adenocarcinoma |
1.7% |
|
| Drug Ineffective |
13.8% |
| Exposure During Pregnancy |
10.3% |
| Haemarthrosis |
6.9% |
| Joint Swelling |
6.9% |
| Off Label Use |
6.9% |
| Psoriasis |
6.9% |
| Alopecia |
3.4% |
| Anaphylactic Shock |
3.4% |
| Arterial Thrombosis |
3.4% |
| Blood Magnesium Decreased |
3.4% |
| Bronchitis Chronic |
3.4% |
| Cellulitis |
3.4% |
| Clostridium Test Positive |
3.4% |
| Condition Aggravated |
3.4% |
| Cushingoid |
3.4% |
| Disseminated Intravascular Coagulation |
3.4% |
| Drug Hypersensitivity |
3.4% |
| Dry Eye |
3.4% |
| Erythema |
3.4% |
| Eyelid Function Disorder |
3.4% |
|
| Secondary |
| Eczema |
11.4% |
| Product Used For Unknown Indication |
10.2% |
| Dermatitis Allergic |
6.8% |
| Dermatitis Atopic |
6.8% |
| Neuropathy Peripheral |
6.8% |
| Diabetes Mellitus |
5.7% |
| Pain |
5.7% |
| Drug Use For Unknown Indication |
4.5% |
| Gestational Diabetes |
4.5% |
| Hiv Infection |
4.5% |
| Insomnia |
4.5% |
| Pain In Extremity |
4.5% |
| Psoriasis |
4.5% |
| Alopecia Areata |
3.4% |
| Hypertension |
3.4% |
| Skin Disorder |
3.4% |
| Blood Pressure |
2.3% |
| Fungal Infection |
2.3% |
| Hypertriglyceridaemia |
2.3% |
| Intervertebral Disc Protrusion |
2.3% |
|
| Drug Ineffective |
12.5% |
| Pruritus |
12.5% |
| Malaise |
8.3% |
| Pustular Psoriasis |
8.3% |
| Tenosynovitis |
8.3% |
| Bone Disorder |
4.2% |
| Cushing's Syndrome |
4.2% |
| Drug Exposure During Pregnancy |
4.2% |
| Foetal Exposure During Pregnancy |
4.2% |
| Glycosylated Haemoglobin Increased |
4.2% |
| Intentional Drug Misuse |
4.2% |
| Joint Swelling |
4.2% |
| Nausea |
4.2% |
| Paraparesis |
4.2% |
| Skin Lesion |
4.2% |
| Superinfection |
4.2% |
| Vaginal Haemorrhage |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.3% |
| Drug Use For Unknown Indication |
15.3% |
| Psoriasis |
10.8% |
| Psoriatic Arthropathy |
3.6% |
| Headache |
3.4% |
| Hypertension |
3.4% |
| Pain |
3.4% |
| Hypersensitivity |
2.8% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Insomnia |
1.9% |
| Nausea |
1.9% |
| Depression |
1.8% |
| Dermatitis Exfoliative |
1.7% |
| Non-small Cell Lung Cancer |
1.7% |
| Rheumatoid Arthritis |
1.7% |
| Arthritis |
1.6% |
| Asthma |
1.2% |
| Restlessness |
1.2% |
| Constipation |
1.1% |
| Hypothyroidism |
1.1% |
|
| Pain |
8.5% |
| Vomiting |
8.5% |
| Tremor |
7.0% |
| Urinary Tract Infection |
7.0% |
| Injection Site Reaction |
5.6% |
| Limb Injury |
5.6% |
| Rash |
5.6% |
| Abortion Spontaneous |
4.2% |
| Drug Ineffective |
4.2% |
| Lung Disorder |
4.2% |
| Progressive Multifocal Leukoencephalopathy |
4.2% |
| Psoriasis |
4.2% |
| Pyrexia |
4.2% |
| Tachycardia |
4.2% |
| Type 1 Diabetes Mellitus |
4.2% |
| Type 2 Diabetes Mellitus |
4.2% |
| Upper Gastrointestinal Haemorrhage |
4.2% |
| Urinary Tract Disorder |
4.2% |
| Aspartate Aminotransferase Increased |
2.8% |
| Death |
2.8% |
|
